Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2019

Open Access 01-06-2019 | Mastectomy | Breast Oncology

Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands

Authors: Annnelotte van Bommel, MD, Pauline Spronk, MD, Marc Mureau, MD, PhD, Sabine Siesling, PhD, Carolien Smorenburg, MD, PhD, Rob Tollenaar, MD, PhD, Marie-Jeanne Vrancken Peeters, MD, PhD, Thijs van Dalen, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2019

Login to get access

Abstract

Background

The rate of breast-conserving surgery (BCS) is used as an esthetic outcome parameter, while other treatments contribute also, such as neoadjuvant chemotherapy (NAC) enabling BCS or immediate breast reconstruction (IBR). This study explores these efforts to preserve the patient’s breast contour.

Patients and Methods

All patients who underwent surgery for invasive breast cancer in The Netherlands between January 2011 and December 2015 were selected from the Dutch national breast cancer audit (n = 61,309). The breast-contour-preserving procedures (BCPP) rate was defined as the rate of primary BCS, BCS after NAC, or mastectomy with IBR. BCPP rates were calculated and compared by year of diagnosis, age categories, and individual hospitals.

Results

The rate of primary BCS remained stable (53%) while the BCPP rate increased from 63% in 2011 to 71% in 2015 due to an increase in patients receiving BCS after NAC and mastectomy with IBR. Primary BCS rates increased with age (from 17% in patients aged < 30 years to 63% in patients aged 60–69 years), while the proportion of patients undergoing mastectomy with IBR decreased from 44% in patients < 30 years to 1% in patients ≥ 70 years. The BCPP rate was similar for all age groups except for patients > 70 years. BCPP rates varied between the different hospitals in The Netherlands, ranging from 47 to 88%.

Conclusions

The chance of preserving the breast contour for patients with breast cancer has increased substantially over recent years. BCPP provides a comprehensive parameter of esthetic outcome of breast cancer surgery.
Literature
2.
go back to reference Aalders KC, van Bommel AC, van Dalen T, et al. Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer. Eur J Cancer (Oxford, England). Aug 2016;63:118–126.CrossRef Aalders KC, van Bommel AC, van Dalen T, et al. Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer. Eur J Cancer (Oxford, England). Aug 2016;63:118–126.CrossRef
3.
go back to reference NABON Breast Cancer Audit. nbca.clinicalaudit.nl. [Accessibility verified September 14, 2017]. NABON Breast Cancer Audit. nbca.clinicalaudit.nl. [Accessibility verified September 14, 2017].
5.
go back to reference Killelea BK, Yang VQ, Mougalian S, et al. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database. J Am Coll Surg. Jun 2015;220(6):1063–1069.CrossRefPubMed Killelea BK, Yang VQ, Mougalian S, et al. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database. J Am Coll Surg. Jun 2015;220(6):1063–1069.CrossRefPubMed
6.
go back to reference Heys SD, Hutcheon AW, Sarkar TK, et al. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clin Breast Cancer. Oct 2002;3 Suppl 2:S69–74.CrossRefPubMed Heys SD, Hutcheon AW, Sarkar TK, et al. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clin Breast Cancer. Oct 2002;3 Suppl 2:S69–74.CrossRefPubMed
7.
go back to reference Freitas-Junior R, Gagliato DM, Moura Filho JWC, et al. Trends in breast cancer surgery at Brazil’s public health system. J Surg Oncol. Apr 2017;115(5):544–549.CrossRefPubMed Freitas-Junior R, Gagliato DM, Moura Filho JWC, et al. Trends in breast cancer surgery at Brazil’s public health system. J Surg Oncol. Apr 2017;115(5):544–549.CrossRefPubMed
8.
go back to reference Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. Jan 2015;150(1):9–16.CrossRefPubMed Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. Jan 2015;150(1):9–16.CrossRefPubMed
9.
go back to reference Ahn SH, Yoo KY. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat. Sep 2006;99(2):209–214.CrossRefPubMed Ahn SH, Yoo KY. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat. Sep 2006;99(2):209–214.CrossRefPubMed
10.
go back to reference Schrodi S, Niedostatek A, Werner C, Tillack A, Schubert-Fritschle G, Engel J. Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data. Eur J Cancer Care. Mar 2015;24(2):242–252.CrossRef Schrodi S, Niedostatek A, Werner C, Tillack A, Schubert-Fritschle G, Engel J. Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data. Eur J Cancer Care. Mar 2015;24(2):242–252.CrossRef
11.
go back to reference Garcia-Etienne CA, Tomatis M, Heil J, et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer (Oxford, England). Sep 2012;48(13):1947–1956.CrossRef Garcia-Etienne CA, Tomatis M, Heil J, et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer (Oxford, England). Sep 2012;48(13):1947–1956.CrossRef
12.
go back to reference McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. Oct 2009;16(10):2682–2690.CrossRefPubMed McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. Oct 2009;16(10):2682–2690.CrossRefPubMed
13.
go back to reference Dragun AE, Huang B, Tucker TC, Spanos WJ. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. Jul–Aug 2012;18(4):318–325.CrossRefPubMed Dragun AE, Huang B, Tucker TC, Spanos WJ. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. Jul–Aug 2012;18(4):318–325.CrossRefPubMed
14.
go back to reference Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM. Are mastectomy rates really increasing in the United States? J Clin Oncol. Jul 20 2010;28(21):3437–3441.CrossRefPubMed Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM. Are mastectomy rates really increasing in the United States? J Clin Oncol. Jul 20 2010;28(21):3437–3441.CrossRefPubMed
15.
go back to reference Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. May 2013;20(5):1436–1443.CrossRefPubMed Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. May 2013;20(5):1436–1443.CrossRefPubMed
16.
go back to reference Chiu AS, Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR. Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB). Am J Surg. Jul 18 2017.CrossRefPubMed Chiu AS, Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR. Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB). Am J Surg. Jul 18 2017.CrossRefPubMed
17.
go back to reference van Steenbergen LN, van de Poll-Franse LV, Wouters MW, et al. Variation in management of early breast cancer in the Netherlands, 2003–2006. Eur J Surg Oncol. Sep 2010;36 Suppl 1:S36–S43.CrossRefPubMed van Steenbergen LN, van de Poll-Franse LV, Wouters MW, et al. Variation in management of early breast cancer in the Netherlands, 2003–2006. Eur J Surg Oncol. Sep 2010;36 Suppl 1:S36–S43.CrossRefPubMed
18.
go back to reference Greenberg CC, Lipsitz SR, Hughes ME, et al. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg. Aug 2011;254(2):339–345.CrossRefPubMedPubMedCentral Greenberg CC, Lipsitz SR, Hughes ME, et al. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg. Aug 2011;254(2):339–345.CrossRefPubMedPubMedCentral
19.
go back to reference Rahal R, Chadder J, DeCaria K, Lockwood G, Bryant H. How different is cancer control across Canada? Comparing performance indicators for prevention, screening, diagnosis, and treatment. Curr Oncol. Apr 2017;24(2):124–128.CrossRefPubMedPubMedCentral Rahal R, Chadder J, DeCaria K, Lockwood G, Bryant H. How different is cancer control across Canada? Comparing performance indicators for prevention, screening, diagnosis, and treatment. Curr Oncol. Apr 2017;24(2):124–128.CrossRefPubMedPubMedCentral
20.
go back to reference Alderman AK, Bynum J, Sutherland J, Birkmeyer N, Collins ED, Birkmeyer J. Surgical treatment of breast cancer among the elderly in the United States. Cancer. Feb 15 2011;117(4):698–704.CrossRefPubMed Alderman AK, Bynum J, Sutherland J, Birkmeyer N, Collins ED, Birkmeyer J. Surgical treatment of breast cancer among the elderly in the United States. Cancer. Feb 15 2011;117(4):698–704.CrossRefPubMed
21.
go back to reference van Bommel AC, Mureau MA, Schreuder K, et al. Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands. J Plast Reconstr Aesthet Surg. Feb 2017;70(2):215–221.CrossRefPubMed van Bommel AC, Mureau MA, Schreuder K, et al. Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands. J Plast Reconstr Aesthet Surg. Feb 2017;70(2):215–221.CrossRefPubMed
22.
go back to reference Kamali P, Paul MA, Ibrahim AM, et al. National and regional differences in 32,248 postmastectomy autologous breast reconstruction using the updated national inpatient survey. Ann Plast Surg. Jan 10 2017.CrossRefPubMed Kamali P, Paul MA, Ibrahim AM, et al. National and regional differences in 32,248 postmastectomy autologous breast reconstruction using the updated national inpatient survey. Ann Plast Surg. Jan 10 2017.CrossRefPubMed
23.
go back to reference Mennie JC, Mohanna PN, O’Donoghue JM, Rainsbury R, Cromwell DA. National trends in immediate and delayed post-mastectomy reconstruction procedures in England: A seven-year population-based cohort study. Eur J Surg Oncol. Jan 2017;43(1):52–61.CrossRefPubMed Mennie JC, Mohanna PN, O’Donoghue JM, Rainsbury R, Cromwell DA. National trends in immediate and delayed post-mastectomy reconstruction procedures in England: A seven-year population-based cohort study. Eur J Surg Oncol. Jan 2017;43(1):52–61.CrossRefPubMed
24.
go back to reference Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. Mar 20 2014;32(9):919–926.CrossRefPubMedPubMedCentral Jagsi R, Jiang J, Momoh AO, et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. Mar 20 2014;32(9):919–926.CrossRefPubMedPubMedCentral
25.
go back to reference Spronk PER, van Bommel ACM, Siesling S, Wouters M, Vrancken Peeters M, Smorenburg CH. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit. Breast (Edinburgh, Scotland). Dec 2017;36:34–38.CrossRef Spronk PER, van Bommel ACM, Siesling S, Wouters M, Vrancken Peeters M, Smorenburg CH. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit. Breast (Edinburgh, Scotland). Dec 2017;36:34–38.CrossRef
26.
go back to reference Mougalian SS, Soulos PR, Killelea BK, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. Aug 01 2015;121(15):2544–2552.CrossRefPubMed Mougalian SS, Soulos PR, Killelea BK, et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. Aug 01 2015;121(15):2544–2552.CrossRefPubMed
27.
go back to reference Graham PJ, Brar MS, Foster T, et al. Neoadjuvant chemotherapy for breast cancer, is practice changing? A population-based review of current surgical trends. Ann Surg Oncol. Oct 2015;22(10):3376–3382.CrossRefPubMed Graham PJ, Brar MS, Foster T, et al. Neoadjuvant chemotherapy for breast cancer, is practice changing? A population-based review of current surgical trends. Ann Surg Oncol. Oct 2015;22(10):3376–3382.CrossRefPubMed
28.
go back to reference Onitilo AA, Onesti JK, Single RM, et al. Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer. PLoS One. 2013;8(12):e84535.CrossRefPubMedPubMedCentral Onitilo AA, Onesti JK, Single RM, et al. Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer. PLoS One. 2013;8(12):e84535.CrossRefPubMedPubMedCentral
29.
go back to reference National Breast Cancer Organization of the Netherlands, [Guideline breast cancer], accessed July 2013. www.oncoline.nl. February 2012. National Breast Cancer Organization of the Netherlands, [Guideline breast cancer], accessed July 2013. www.​oncoline.​nl. February 2012.
30.
go back to reference Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer (Oxford, England: 1990). Sep 2010;46(13):2344–2356.CrossRef Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer (Oxford, England: 1990). Sep 2010;46(13):2344–2356.CrossRef
31.
go back to reference Schreuder K, van Bommel ACM, de Ligt KM, et al. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands. Breast (Edinburgh, Scotland). May 24 2017;34:96–102.CrossRef Schreuder K, van Bommel ACM, de Ligt KM, et al. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands. Breast (Edinburgh, Scotland). May 24 2017;34:96–102.CrossRef
32.
go back to reference van Bommel ACM, Schreuder K, Veenstra RK, et al. Discrepancies between surgical oncologists and plastic surgeons in patient information provision and personal opinions towards immediate breast reconstruction. Ann Plast Surg. Jul 31 2018.CrossRefPubMed van Bommel ACM, Schreuder K, Veenstra RK, et al. Discrepancies between surgical oncologists and plastic surgeons in patient information provision and personal opinions towards immediate breast reconstruction. Ann Plast Surg. Jul 31 2018.CrossRefPubMed
Metadata
Title
Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands
Authors
Annnelotte van Bommel, MD
Pauline Spronk, MD
Marc Mureau, MD, PhD
Sabine Siesling, PhD
Carolien Smorenburg, MD, PhD
Rob Tollenaar, MD, PhD
Marie-Jeanne Vrancken Peeters, MD, PhD
Thijs van Dalen, MD, PhD
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07265-3

Other articles of this Issue 6/2019

Annals of Surgical Oncology 6/2019 Go to the issue